Pfizer SG&A Expenses 2010-2024 | PFE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pfizer annual sg&a expenses for 2024 were $14.73B, a 0.28% decline from 2023.
Pfizer annual sg&a expenses for 2023 were $14.771B, a 8% increase from 2022.
Pfizer annual sg&a expenses for 2022 were $13.677B, a 7.67% increase from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Pfizer annual sg&a expenses for 2024 were $14.73B, a 0.28% decline from 2023.
Pfizer annual sg&a expenses for 2023 were $14.771B, a 8% increase from 2022.
Pfizer annual sg&a expenses for 2022 were $13.677B, a 7.67% increase from 2021.